April 21, 2026
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJuly 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJuly 24, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreApril 21, 2026
Market insights predict, the veterinary CRO and CDMO industry is expected to grow from USD 7.17 billion in 2024 to USD 16.13 billion by 2034, driven by a CAGR of 8.43%. The market is growing due to rising pet ownership and increased focus on animal health. Pharma companies are outsourcing R&D and manufacturing to reduce costs and speed up produ...
April 21, 2026
Numerous benefits of automated labelling systems, like cost-effectiveness, more efficiency, and overall enhanced productivity in the pharmaceutical and healthcare sectors are driving the global market growth. However, North America led the market due to early UDI adoption, FDA mandates, and a mature digital infrastructure....
April 21, 2026
The increasing adoption of advanced technologies in healthcare and the growing need for data privacy drive the global market. North America led the market owing to the presence of key players and a robust healthcare infrastructure....
April 21, 2026
According to forecasts, the global Cell-Based Immunotherapies market will grow from USD 4.59 billion in 2024 to USD 18.62 billion by 2034, with an expected CAGR of 15.02%. The cell-based immunotherapies market is growing due to rising cancer incidence and increasing for personalized, targeted treatment approaches. Advanced in cell engineering and r...
April 21, 2026
Market insights predict the global life science plastic bottles industry will increase from USD 6.54 billion in 2024 to USD 11.97 billion by 2034, achieving a CAGR of 6.24%. The growing research and development activities and the growing demand for single-use equipment drive the global market. The increasing R&D investments and the presence of ...
April 21, 2026
Based on market forecasts, the breast cancer liquid biopsy sector will expand from USD 229.6 million in 2025 to USD 912.83 million by 2035, experiencing a CAGR of 14.8%. Breast cancer cases are rising day by day, which is increasing the demand for biopsy, leading to the significant growth of the breast cancer liquid biopsy market. North America is ...
April 21, 2026
Market insights predict the global life science cloud industry will increase from USD 25.28 billion in 2024 to USD 105.05 billion by 2034, achieving a CAGR of 15.27%.The rapid adoption of cloud solutions in the development of precision medicine, clinical trials, and other life science sectors is driving the global market. From this, North America l...
April 21, 2026
Projections indicate that, progressive pulmonary fibrosis (PPF) treatment industry is projected to rise from USD 0.6 billion in 2024 to USD 2.45 billion by 2034, reflecting a CAGR of 15.21% over the next decade. The Progressive Pulmonary Fibrosis (PPF) treatment market is growing because the prevalence of this condition is growing, likely due to a ...
April 21, 2026
According to market projections, the global NGS-based RNA-sequencing market, valued at USD 3.74 billion in 2024, is anticipated to reach USD 23.52 billion by 2034, growing at a CAGR of 20.1% over the next decade. The market is expanding due to its high accuracy in analyzing gene expression and detecting rare transcripts. Growing use in disease rese...
April 21, 2026
Projections indicate that, the global life science products market will increase from USD 3.15 billion in 2024 to USD 8.65 billion by 2034, experiencing a CAGR of 10.56% over the next 10 years.The life science products market is expanding due to growing chronic diseases as well as increasing prenatal diagnostics. North America led the market due to...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
